| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Biochemistry, McGill Cancer Centre; 2 Department of Oncology, McGill University; 3 Cancer Prevention Centre, Jewish General Hospital, Montreal, Quebec, Canada; and 4 Department of Medicine and Physiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Requests for reprints: Nahum Sonenberg, Department of Biochemistry, McGill Cancer Centre, McIntyre Medical Sciences Building, 3655 Sir William Osler, Room 807, Montreal, Quebec, Canada, H3G 1Y6. Phone: 514-398-7274; Fax: 514-398-1287; E-mail: nahum.sonenberg{at}mcgill.ca.
Metformin is used for the treatment of type 2 diabetes because of its ability to lower blood glucose. The effects of metformin are explained by the activation of AMP-activated protein kinase (AMPK), which regulates cellular energy metabolism. Recently, we showed that metformin inhibits the growth of breast cancer cells through the activation of AMPK. Here, we show that metformin inhibits translation initiation. In MCF-7 breast cancer cells, metformin treatment led to a 30% decrease in global protein synthesis. Metformin caused a dose-dependent specific decrease in cap-dependent translation, with a maximal inhibition of 40%. Polysome profile analysis showed an inhibition of translation initiation as metformin treatment of MCF-7 cells led to a shift of mRNAs from heavy to light polysomes and a concomitant increase in the amount of 80S ribosomes. The decrease in translation caused by metformin was associated with mammalian target of rapamycin (mTOR) inhibition, and a decrease in the phosphorylation of S6 kinase, ribosomal protein S6, and eIF4E-binding protein 1. The effects of metformin on translation were mediated by AMPK, as treatment of cells with the AMPK inhibitor compound C prevented the inhibition of translation. Furthermore, translation in MDA-MB-231 cells, which lack the AMPK kinase LKB1, and in tuberous sclerosis complex 2 null (TSC2–/–) mouse embryonic fibroblasts was unaffected by metformin, indicating that LKB1 and TSC2 are involved in the mechanism of action of metformin. These results show that metformin-mediated AMPK activation leads to inhibition of mTOR and a reduction in translation initiation, thus providing a possible mechanism of action of metformin in the inhibition of cancer cell growth. [Cancer Res 2007;67(22):10804–12]
This article has been cited by other articles:
|
|
 |
|
  B. Martin-Castillo, J. Dorca, A. Vazquez-Martin, C. Oliveras-Ferraros, E. Lopez-Bonet, M. Garcia, S. del Barco, and J. A. Menendez Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology Ann. Onc., November 2, 2009; (2009) mdp494v1. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kisfalvi, G. Eibl, J. Sinnett-Smith, and E. Rozengurt Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth Cancer Res., August 15, 2009; 69(16): 6539 - 6545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. OLIVEIRA, R. ARANTES-RODRIGUES, C. SOUSA-DINIZ, A. COLACO, L. LOURENCO, L. FELIPE. DE LA CRUZ P., V. M. DA SILVA, J. AFONSO, C. LOPES, and L. SANTOS The Effects of Sirolimus on Urothelial Lesions Chemically Induced in ICR Mice by BBN Anticancer Res, August 1, 2009; 29(8): 3221 - 3226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pollak Macronutrient Intake and Cancer: How Does Dietary Restriction Influence Tumor Growth and Why Should We Care? Cancer Prevention Research, August 1, 2009; 2(8): 698 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jiralerspong, S. L. Palla, S. H. Giordano, F. Meric-Bernstam, C. Liedtke, C. M. Barnett, L. Hsu, M.-C. Hung, G. N. Hortobagyi, and A. M. Gonzalez-Angulo Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer J. Clin. Oncol., July 10, 2009; 27(20): 3297 - 3302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saito, A. Furuno, J. Sakurai, A. Sakamoto, H.-R. Park, K. Shin-ya, T. Tsuruo, and A. Tomida Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation Cancer Res., May 15, 2009; 69(10): 4225 - 4234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Meric-Bernstam and A. M. Gonzalez-Angulo Targeting the mTOR Signaling Network for Cancer Therapy J. Clin. Oncol., May 1, 2009; 27(13): 2278 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vazquez-Martin, C. Oliveras-Ferraros, S. del Barco, B. Martin-Castillo, and J. A. Menendez The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy Ann. Onc., March 1, 2009; 20(3): 592 - 595. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Menendez, A. Vazquez-Martin, F. J. Ortega, and J. M. Fernandez-Real Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer Clin. Chem., March 1, 2009; 55(3): 425 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fan, C. Ma, and H. Zhang The molecular mechanisms that underlie the tumor suppressor function of LKB1 Acta Biochim Biophys Sin, February 1, 2009; 41(2): 97 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, P. Hao, S. Zheng, K. Tu, H. Fan, R. Zhu, G. Ding, C. Dong, C. Wang, X. Li, et al. Gene expression module-based chemical function similarity search Nucleic Acids Res., November 1, 2008; 36(20): e137 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zakikhani, R. J.O. Dowling, N. Sonenberg, and M. N. Pollak The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase Cancer Prevention Research, October 1, 2008; 1(5): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
